A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Seong A. | - |
dc.contributor.author | Kim, Seohyun | - |
dc.contributor.author | Kim, Gi Beom | - |
dc.contributor.author | Goo, Jiyoung | - |
dc.contributor.author | Kim, Nayeon | - |
dc.contributor.author | Lee, Yeram | - |
dc.contributor.author | Nam, Gi-Hoon | - |
dc.contributor.author | Lim, Seungho | - |
dc.contributor.author | Kim, Taeerk | - |
dc.contributor.author | Chang, Ki Hwan | - |
dc.contributor.author | Lee, Tae Gyu | - |
dc.contributor.author | Kim, In-San | - |
dc.contributor.author | Lee, Eun Jung | - |
dc.date.accessioned | 2022-08-26T01:40:19Z | - |
dc.date.available | 2022-08-26T01:40:19Z | - |
dc.date.created | 2022-08-25 | - |
dc.date.issued | 2022-06 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/143410 | - |
dc.description.abstract | The SARS-CoV-2 pandemic has created a global public crisis and heavily affected personal lives, healthcare systems, and global economies. Virus variants are continuously emerging, and, thus, the pandemic has been ongoing for over two years. Vaccines were rapidly developed based on the original SARS-CoV-2 (Wuhan-Hu-1) to build immunity against the coronavirus disease. However, they had a very low effect on the virus' variants due to their low cross-reactivity. In this study, a multivalent SARS-CoV-2 vaccine was developed using ferritin nanocages, which display the spike protein from the Wuhan-Hu-1, B.1.351, or B.1.429 SARS-CoV-2 on their surfaces. We show that the mixture of three SARS-CoV-2 spike-protein-displaying nanocages elicits CD4(+) and CD8(+) T cells and B-cell immunity successfully in vivo. Furthermore, they generate a more consistent antibody response against the B.1.351 and B.1.429 variants than a monovalent vaccine. This leads us to believe that the proposed ferritin-nanocage-based multivalent vaccine platform will provide strong protection against emerging SARS-CoV-2 variants of concern (VOCs). | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | SPIKE | - |
dc.subject | NANOPARTICLES | - |
dc.subject | INFECTIVITY | - |
dc.subject | DESIGN | - |
dc.title | A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, In-San | - |
dc.identifier.doi | 10.3390/ijms23116123 | - |
dc.identifier.scopusid | 2-s2.0-85131710826 | - |
dc.identifier.wosid | 000808695500001 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.23, no.11 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.citation.title | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.citation.volume | 23 | - |
dc.citation.number | 11 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | SPIKE | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | INFECTIVITY | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordAuthor | protein nanocage | - |
dc.subject.keywordAuthor | ferritin | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | variants | - |
dc.subject.keywordAuthor | multivalent vaccine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.